Source: Annual Congress 2004 - Clinical studies on acute respiratory failure in COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
I. Yaldiz, U. Gonlugur, I. Akkurt (Sivas, Turkey). Possible anticoagulant effect of exacerbations on COPD. Eur Respir J 2004; 24: Suppl. 48, 3362

Member's Comments

No comment yet.

Related content which might interest you: Pharmacologic treatment of exacerbations of COPD Source: International Congress 2016 – Management of COPD exacerbations: A European Respiratory Society/American Thoracic Society (ERS/ATS) guideline Year: 2016 Increased platelet reactivity during acute exacerbations of COPD, irrespective of antiplatelet therapy Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD Year: 2015 Duration of systemic corticosteroids treatment in COPD exacerbations Source: Annual Congress 2008 - Pathogenesis and treatment of asthma and COPD Year: 2008 Impact of halotherapy on COPD exacerbations Source: International Congress 2019 – COPD treatment: cohorts and real-world studies Year: 2019 Effect of roflumilast on exacerbations in patients with severe COPD and a prior history of hospitalization taking combination therapy Source: International Congress 2015 – Advances in the future treatment of COPD Year: 2015 The effect of bronchiectasis on asthma exacerbations Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management Year: 2012 Recommendations for pharmacological treatment of exacerbations of COPD Source: International Congress 2017 – Treatment and prevention of COPD exacerbation Year: 2017 COPD exacerbations: impact and prevention Source: Breathe 2013; 9: 434-440 Year: 2013 Corticosteroids and exacerbations of COPD Source: Annual Congress 2007 - Corticosteroids and respiratory failure Year: 2007 Evaluation of COPD exacerbations using the EXACT-U Source: Annual Congress 2010 - COPD exacerbation Year: 2010 Ceruloplasmine efficacy in patients with asthma exacerbations Source: Annual Congress 2011 - Novel mechanisms in lung injury Year: 2011 Modelling exacerbations of COPD Source: Annual Congress 2012 - Modelling respiratory infections: is it the future or the present? Year: 2012 Mechanism by which inhaled bronchodilators prevent exacerbations in chronic obstructive pulmonary disease Source: Annual Congress 2013 –Asthma and COPD drugs: efficacy, safety and pharmacoeconomics Year: 2013 Screening eosinophil counts and risk of exacerbations after inhaled corticosteroid withdrawal in severe COPD Source: International Congress 2016 – Novel avenues in the treatment of COPD II Year: 2016 The direct costs of exacerbations in COPD and the effect of cilomilast treatment Source: Eur Respir J 2002; 20: Suppl. 38, 245s Year: 2002 Impact of cardiovascular comorbidities on COPD exacerbations Source: Annual Congress 2007 - COPD and comorbidity Year: 2007 Macrolides in the prevention of COPD exacerbations Source: Annual Congress 2012 - Non-antibiotic effects of macrolides in lung disease Year: 2012 The effect of tiotropium in COPD complicated with asthma Source: Annual Congress 2007 - New insights into the treatment of COPD Year: 2007 The effect on mortality of adding inhaled corticosteroids to long-acting bronchodilators for COPD: A focus on the frequent exacerbator phenotype Source: International Congress 2015 – COPD and lung function: risk factors and outcomes Year: 2015